shown to form homo-and heterodimers, it is believed that the ratios of anti-to pro-apoptotic proteins may play a regulatory Epidemiological studies have linked dietary fiber to the role in apoptosis (11). Overexpression of Bcl-2 has been shown prevention of human colorectal cancer and suggest that to suppress the initiation of apoptosis in response to a number short chain fatty acids such as butyric acid, which is of stimuli, whereas inhibition of Bcl-2 expression has been produced by fermentation of dietary fiber in the large shown to promote apoptosis (10). Thus, the sensitivity of intestine, may be an important mediator of the protective cancer cells to apoptotic signal(s) may depend on the levels effects of fiber. We investigated the role of Bcl-2 deregulaof Bcl-2 or related family members. Recent studies have tion on the sensitivity of colorectal carcinoma cells to indicated that apoptosis may be an integral part of normal undergo butyrate-induced apoptosis. Here we report an events in the colon in vivo (12) and deregulation of apoptosis inverse relationship between the levels of Bcl-2 and the may be involved in the development of colorectal cancer (13).
sensitivity of colorectal carcinoma cell lines to undergo
Since colonic epithelial cells near the top of the crypt and in apoptosis in response to butyrate. Overexpression of Bcl-2 in colorectal carcinoma DiFi cells resulted in suppression the lumen have been shown to undergo apoptosis (12) and of butyrate-induced apoptosis and enhanced cell survival butyrate is a locally produced SCFA in the large bowel (2), in response to butyrate. Butyrate-induced apoptosis was one potential mechanism of the protective effects of dietary accompanied by inhibition of expression of a 30 kDa protein fiber against development of colorectal cancer may include (p30, immunorecognized by anti-Bcl-2 mAb) and this cellumodulation of the apoptotic pathway(s) of butyrate. The present lar effect of butyrate was inhibited by Bcl-2 overexpression.
investigation was undertaken to investigate the role of Bcl-2 These findings suggest that deregulation of Bcl-2 in human deregulation on the apoptotic sensitivity of colorectal carcincolorectal carcinoma cells confers resistance to induction oma cells in response to butyrate. of apoptosis by butyrate, a dietary micronutrient.
Human colorectal carcinoma DiFi (14,15) [original source Dr Bruce M.Boman (14)] SW-480 and HCT-116 (American Type Culture Collection) cells were maintained in DMEMϪ F12 (1:1) supplemented with 10% fetal calf serum. Cell growth Epidemiological and experimental studies have linked dietary was measured by the MTT method (7). Apoptotic cell death fiber to the prevention of colorectal cancer (1), but the was quantified by an ELISA assay (Boehringer) that measures mechanism(s) involved remains poorly understood. Exploracytoplasmic histone-bound DNA fragments (mono-and oligotion of active micronutrient(s) with growth inhibitory properties nucleosomes) generated during apoptosis (7). To assay DNA could provide new tools for prevention and treatment of human fragmentation, low molecular weight DNA was isolated and colorectal cancer. One such dietary micronutrient is sodium analyzed by 1.5% agarose gel electrophoresis. Both floating butyrate (butyrate*), the major short chain fatty acid (SCFA) and attached cells were used in apoptotic assays. To overexpress produced by fermentation of dietary fiber in the large intestine Bcl-2, DiFi cells were plated a density of 10 6 cells/100 mm (2). In general, one half of total SCFAs (300 mmol/day) diameter plate and transfected with plasma DNA containing generated from fermentation of fiber by endogenous intestinal the full-length human Bcl-2 cDNA and a selection marker, the bacteria are known to be structurally related to butyric acid neomycin phosphotransferase gene (16), by calcium phosphate (2,3). Studies using in vivo models have shown that dietary procedures as described (7). As a control, we have used DiFi fiber supplementation led to increased colonic butyrate levels cells stably transfected with a control vector containing the and these changes were associated with reduced colonic cell proliferation (4) and also lower tumor mass (5) . Butyrate is a neomycin phosphotransferase gene. For immunoblotting, cell known potent growth inhibitor and differentiating agent for a lysates containing equal amounts of total protein were resolved number of cancer cells, including colorectal, and recently was on a 12% SDSϪPAGE followed by probing with an anti-Bclshown to induce apoptosis in human colorectal carcinoma cells 2 mAb (Dako) or anti-Bax antibody (Santa Cruz). Immune (6-9).
complexes were detected using an alkaline phosphatase-conjugHomeostasis in colonic epithelial cells is regulated by a ated secondary antibody (7,17). Quantification was performed balance between proliferative activity and cell loss. Apoptosis with a protein scanner (Molecular Dynamics). is a physiological mechanism of cell loss that is dependent on
To examine the possible involvement of apoptosis in the both pre-existing proteins and de novo protein synthesis action of butyrate in colon cancer cells, we examined the effect of butyrate on apoptotic cell death in three human colorectal cell lines using a quantitative ELISA assay. The results in Figure 1A show that HCT-116 cells were least sensitive (1.87-fold compared with untreated cells) and DiFi cells were most sensitive (5.76-fold compared with untreated cells) to butyrate-induced apoptosis. Similar results were also obtained by DNA fragmentation assay (data not shown). Since apoptosis in mammalian cells has been shown to be modulated by Bcl-2, we next investigated whether butyrate-induced apoptosis in colorectal carcinoma cells was related to the levels of Bcl-2. As shown in Figure 1B either high levels of Bcl-2 (DiFi/BCL2 cells) or control neomycin phosphotransferase (DiFi/Neo cells) were generated. Figure 2 shows the levels of Bcl-2 protein in six such cells (Figure 3) . The observed survival of Bcl-2-overexpressing cells was dependent on the duration of treatment, with clones which overexpress 6-to 10-fold higher levels of Bcl-2 compared with control DiFi cells. Reprobing of the Bcl-2 blot maximum protection observed by 48 h after treatment (4-15% growth inhibition in clones compared with 48% growth with an anti-Bax antibody (lower blot) indicated that there was no effect of Bcl-2 overexpression on the levels of inhibition at 1 mM butyrate in DiFi cells). Deregulation of Bcl-2-protected DiFi cells from the growth inhibitory effects expression of pro-apoptotic Bax protein, and also on another anti-apoptotic Bcl-XL protein (Pame B).
of butyrate at both 1 ( Figure 3A ) and 3 mM ( Figure 3B ) concentrations. Results in Figure 3 show the effect of overexpression of Bcl-2 on the sensitivity of two independent DiFi/BCL2 clones Next we examined the effect of Bcl-2 overexpression in DiFi cells on the ability of butyrate to induce apoptosis using to the growth inhibitory effect of butyrate. Both Bcl-2 overexpressing clones were protected from the growth inhibitory quantitative ELISA and DNA fragmentation assays. Figure 4A shows the results of a quantitative ELISA assay, demonstrating action of butyrate in a time-and dose-dependent manner compared with growth inhibition of DiFi cells or DiFi/Neo-2 that Bcl-2 overexpression in DiFi/BCL2-2 and DiFi/BCL2-5 cells leads to a significant suppression of butyrate-induced Bcl-2 mAb used here distinctively recognized a protein of 30 kDa (p30) in DiFi cells ( Figure 5A , lanes 1-5) but not in apoptosis (1.4-to 1.9-fold increase in apoptosis compared with 4.2-fold apoptosis in the control DiFi cells by 48 h treatment Bcl-2 overexpressing cells ( Figure 5A , lanes 6-10). The levels of p30 were down-regulated in a time-dependent manner in with 1 mM butyrate). As shown in Figure 4B , there was significant suppression of butyrate-induced DNA fragmentation butyrate-treated DiFi cells ( Figure 5A ). In brief, these results suggest that p30 may be either post-translationally modified in both DiFi/BCL2-2 (lanes 3 and 4) and DiFi/BCL2-5 cells (lanes 5 and 6) compared with the extent of DNA fragmentation Bcl-2 or a related protein present in cells such as DiFi with very low levels of Bcl-2. observed in either DiFi cells (lanes 1 and 2) or DiFi/Neo-2 cells (data not shown). These results suggest that overexpression of In summary, the results presented here demonstrate an Bcl-2 suppresses butyrate-induced apoptosis and enhances cell survival.
Since butyrate has been shown to down-regulate the levels of Bcl-2 in other cell types (7,18), we investigated the effect of butyrate on the levels of Bcl-2 in DiFi/BCL2-5 versus DiFi cells or DiFi/Neo-2 cells (as negative controls). As shown in Figure 5A , there was no significant effect of 1 ( Figure 5A , lanes 6-10) or 3 mM butyrate ( Figure 5B, lanes 3 and 4) on the levels of Bcl-2 in DiFi/BCL2-5 cells. There was also no effect of butyrate on the levels of Bcl-2 expression in DiFi/ BCL2-2 or HCT-116 cells (data not shown). These results suggest that butyrate may utilize different mechanisms to induce apoptosis in different cell types. However, the anti- 2) and DiFi/BCL2-5 (lanes 3 and 4) cells were not treated 48-well plate. After 24 h (0 time), some cells were treated or not in quadruplicate with 1 (A) or 3 mM (B) butyrate for the indicated periods.
(lanes 1 and 3) or were treated with 3 mM butyrate (lanes 2 and 4) for 24 h and immunoblotted with an anti-Bcl-2 mAb. As an internal control, the Cell growth was determined by MTT assay. The growth of control DiFi cells was increased by 2.8Ϯ0.3-fold during the 4 days. Results are presented upper part of the blot was immunoblotted with an unrelated mAb against heat shock protein 70. as percentage of controls for each cell line. Bars, SEM (n ϭ 4). shown to be associated with inhibition of apoptosis (13) transgene can down-regulate endogenous Bcl-2 levels (19). 
